AAAAAA
Results:
1-13
|
Results: 13
Authors:
Maung, HM
Elangovan, L
Frazao, JM
Bower, JD
Kelley, BJ
Acchiardo, SR
Rodriguez, HJ
Norris, KC
Sigala, JF
Rutkowski, M
Robertson, JA
Goodman, WG
Levine, BS
Chesney, RW
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Hm. Maung et al., Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison, AM J KIDNEY, 37(3), 2001, pp. 532-543
Authors:
Levine, BS
Anderson, BJ
Butler, DA
Antisdel, JE
Brackett, J
Laffel, LMB
Citation: Bs. Levine et al., Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes, J PEDIAT, 139(2), 2001, pp. 197-203
Authors:
Levine, BS
Citation: Bs. Levine, Labor statistics measurement issues., IND LAB REL, 55(1), 2001, pp. 183-185
Authors:
Brown, AP
Dinger, N
Levine, BS
Citation: Ap. Brown et al., Stress produced by gavage administration in the rat, CONT T LAB, 39(1), 2000, pp. 17-21
Authors:
Levine, BS
Citation: Bs. Levine, Nicotine safety and toxicity, AM J ADDICT, 9(2), 2000, pp. 179-179
Authors:
Frazao, JM
Elangovan, L
Maung, HM
Chesney, RW
Acchiardo, SR
Bower, JD
Kelley, BJ
Rodriguez, HJ
Norris, KC
Robertson, JA
Levine, BS
Goodman, WG
Gentile, D
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Jm. Frazao et al., Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism, AM J KIDNEY, 36(3), 2000, pp. 550-561
Authors:
Ripple, MG
Pestaner, JP
Levine, BS
Smialek, JE
Citation: Mg. Ripple et al., Lethal combination of tramadol and multiple drugs affecting serotonin, AM J FOREN, 21(4), 2000, pp. 370-374
Authors:
Jufer, RA
Wstadik, A
Walsh, SL
Levine, BS
Cone, EJ
Citation: Ra. Jufer et al., Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers, J ANAL TOX, 24(7), 2000, pp. 467-477
Authors:
Kirchner, DL
Mercieca, MD
Crowell, JA
Levine, BS
Citation: Dl. Kirchner et al., Developmental toxicity studies of 2-(difluoromethyl)-dl-ornithine (DFMO) in rats and rabbits, TOXICOL SCI, 50(1), 1999, pp. 127-135
Authors:
Levine, BS
Youssef, A
Kirchner, DL
Mercieca, MD
Citation: Bs. Levine et al., Retinyl palmitate as a positive control agent in rat and rabbit developmental toxicity studies, TOX METHOD, 9(4), 1999, pp. 229-243
Authors:
Levine, BS
Carpenter, TO
Citation: Bs. Levine et To. Carpenter, Evaluation and treatment of heritable forms of rickets, ENDOCRINOLO, 9(5), 1999, pp. 358-365
Authors:
Brown, AP
Morrissey, RL
Crowell, JA
Levine, BS
Citation: Ap. Brown et al., Difluoromethylornithine in combination with tamoxifen in female rats: 13-week oral toxicity study, CANC CHEMOT, 44(6), 1999, pp. 475-483
Authors:
Brown, AP
Morrissey, RL
Crowell, JA
Levine, BS
Citation: Ap. Brown et al., Thirteen-week oral toxicity study of difluoromethylornithine in combination with tamoxifen citrate in female dogs, CANC CHEMOT, 43(6), 1999, pp. 479-488
Risultati:
1-13
|